The Czech Republic has observed a 0.83 million (0.9%) increase in the research & development by business enterprise, pharmaceutical industry in constant ppp $, which now stands at 91.31 million.
Research & development by business enterprise, pharmaceutical industry in constant PPP $ in the Czech Republic
No matching regions
More indicators for the Czech Republic
Government R&D in security as % of government support
0.3%
-0.64%
(2021)
R&D financed by rest of the world in local currency
415,913.40M
+43,474.09M
(2022)
Government R&D financed by rest of the world in local currency
40,048.76M
+2,660.91M
(2022)
Business R&D financed by rest of the world in local currency
334,813.62M
+39,228.60M
(2022)
Non-profit R&D growth rate
32.43%
+38.54%
(2022)
Czech Republic Business R&D pharmaceutical in constant PPP $ between 1996 and 2022
| Period | Value | Change |
|---|---|---|
| 2022 | 91.31M | +0.83M |
| 2021 | 90.48M | +1.16M |
| 2020 | 89.32M | +0.85M |
| 2019 | 88.47M | -12.86M |
| 2018 | 101.33M | +17.37M |
| 2017 | 83.96M | -3.00M |
| 2016 | 86.96M | +0.07M |
| 2015 | 86.89M | +3.02M |
| 2014 | 83.88M | +5.11M |
| 2013 | 78.76M | -11.83M |
| 2012 | 90.59M | +1.96M |
| 2011 | 88.64M | +1.88M |
| 2010 | 86.75M | -9.77M |
| 2009 | 96.53M | +6.24M |
| 2008 | 90.29M | -2.95M |
| 2007 | 93.23M | +12.66M |
| 2006 | 80.58M | +9.58M |
| 2005 | 70.99M | -6.54M |
| 2004 | 77.54M | +28.16M |
| 2003 | 49.37M | -5.34M |
| 2002 | 54.71M | +13.54M |
| 2001 | 41.17M | +3.08M |
| 2000 | 38.09M | +12.11M |
| 1999 | 25.98M | +4.82M |
| 1998 | 21.16M | +4.71M |
| 1997 | 16.45M | -8.67M |
| 1996 | 25.12M |